>
Bessent Pulls Trigger On Using Frozen Funds To Reimburse Gulf Allies: 'Iran Will Pay'
ActBlue CEO Pleads The Fifth During House Panel Hearing
A Historic Energy Squeeze Is Locked In: U.S. Oil Inventories Have Fallen For 7 Weeks In A Row...
USPS Proposes Halting Mail Ballot Delivery To States That Refuse Voter Roll Verification
NUCLEAR ENGINE - UNLIMITED LUXURY - 20 YEARS WITHOUT REFUELING
China Unveils Nuclear-Powered Floating Hub For Green Shipping
China Launches World's 1st Commercial Brain Chip, Beating Elon Musk's Neuralink!
Modular next-gen US nuclear reactor goes critical
This Company Will Add Phone, AirPod, and Smartwatch Trackers to License Plate Readers
Elon Details SpaceX AI Data Center in Space Details and Roadmap
5-in-1 miniature surgical robot is the size of a seed
Every hard drive you own will die.
Flying car industry turns to solid-state batteries for commercial takeoff

Craig Venter thinks that sending living organisms to other galaxies on spaceships is "definitely" science fiction. It's much more realistic, he thinks, to print them on-site using digital representations of their genome. He calls this "biological teleportation."
Essentially emailing medicine and organisms back and forth between Earth and other planets is just one of the far-future implications of a device developed by Synthetic Genomics, a company founded by Venter, a superstar geneticist and biotechnologist. The tabletop device is called the Digital-to-Biological Converter, or DBC for short, and without a fancy box it looks like a bunch of complicated mechanical crap laid out on a table. The device accepts digital representations of DNA over the internet and reconstructs them on the spot using the chemical building blocks of life—adenine, cytosine, guanine, and thymine. You might recognize their initials from the movie Gattaca.